Dedalus & IBEX launch AI pathology for cancer diagnosis in Europe

Dedalus and Ibex Launch an End-to-End AI-powered Digital Pathology Solution, Streamlining Cancer Diagnosis Across Europe


Milan, Italy, Nov 30th – Dedalus Group (“Dedalus”), the leading anatomic pathology information systems provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the launch of a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis.

The new solution is now commercially available in major European markets and sets a new standard for anatomic pathology lab digitization by seamlessly integrating Ibex’s GalenTM platform into Dedalus’ comprehensive Digital Pathology (DP) Solution. It enables full digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) & DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses.

Find out more

Please open in latest version of Chrome, Firefox, Safari browser for best experience or update your browser.

Update Browser